BioPharma Reporter

NOVEMBER 21, 2022

Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.

Insulin 98

Insulin Drug Delivery Development Drugs 98

pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 110

Drug Delivery Insulin Cosmetics Development 110

Camargo

OCTOBER 14, 2020

The establishment of the DHCoE is the latest of many signs that the FDA is working closely with other stakeholders to make sure that regulations keep pace with the rapid advancements in this space. ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD).

Development 196

Development Insulin Drug Delivery Production 196

pharmaphorum

JUNE 10, 2021

Simply put, the revenues and profits from today’s mainstream drugs fund the scientific discovery that make tomorrow’s breakthrough drugs and critical vaccines possible. The truth about rising drug prices is more nuanced and merits exploration. The Big Misconception.

Manufacturing 105

Manufacturing Pharma Companies Drugs Pharmacy 105

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Combination products might be part drug, part device, or part software or hardware. By John W.M.

Regulation 59

Regulation Production Drug Delivery Insulin 59